Significant Reduction in Incontinence Episodes with OnabotulinumtoxinA and Clinically Meaningful Improvements in the Practical Aspects of Overactive Bladder Patients’ Daily Lives in Real-world Clinical Practice

Research Type

Clinical

Abstract Category

Overactive Bladder

Watch this session

Links
	Abstract 445
	Lower Urinary Tract Symptoms Scientific Podium Short Oral Session 20
	Thursday 14th September 2017
	14:22 - 14:30
	Cavaniglia A
	Overactive Bladder Prospective Study Incontinence Urgency Urinary Incontinence Quality of Life (QoL)
	1. University College London Hospitals, London, UK, 2. University Hospital of Salamanca, Salamanca, Spain, 3. Ecron Acunova, Frankfurt, Germany, 4. Allergan plc, Irvine, CA, USA, 5. Södersjukhuset, Stockholm South General Hospital, Stockholm, Sweden
Presenter
R Rizwan Hamid
Abstract PDF Edit Abstract Abstract Centre